Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Two Gelatine Solutions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion:~* Male or female patients \>= 18 years of age and \<= 90 years of age. Women of child bearing potential must test negative on standard pregnancy test.~* Patients scheduled to undergo elective abdominal surgery (e.g. Rectal resection, liver resection, open bowl resection, duodenopancreatectomy reconstitution).~* Scheduled intraoperative volume requirement of at least 15 ml / kg body weight (BROCA) gelatine solution~* Provision of voluntary consent to participate in the study, following a full explanation of the nature and purpose of the study, by signing the informed consent form approved by the Institutional Ethics Committee (IEC) prior to all evaluations.~Exclusion:~* Patients of ASA-class \> III~* Known hypersensitivity to gelatine or to any of the constituents of the solution~* Patients treated with other colloid solutions and / or blood products 24 hours prior to surgery~* Patients on hemodialysis~* Patients suffering from decompensated renal function (i.e. serum creatinine \> 3.0 mg/dl)~* Patients suffering from Hypervolemia Hyperhydration Severe blood coagulation disorders Hypernatremia (serum(Na+) \> 150 mmol/L) Hyperchloremia (serum(Cl-) \> 110 mmol/L)~* Estimated perioperative need for blood products of 3,5 ml / kg body weight (BROCA)~* Lactation period~* Simultaneous participation in another clinical trial~* Emergencies

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- balanced gelatine solution (Type: EXPERIMENTAL): isotonic colloidal volume substitute
- non-balanced gelatine solution (Type: ACTIVE_COMPARATOR): colloidal volume substitute

Based on this trial design, predict the completion outcome and termination type (if applicable).